AbbVie Inc.
ABBV 232.36 (0.40%) 0.92
Health Care
Biotechnology
Quality Checklist 1/8
Est. EPS Growth > 5%
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Quick Ratio > 1
Net Margin > 10%
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $410.67(B)
EV: $473.89(B)
Total Equity: $-2.60(B)
Earnings date: Jan-30-2026
P/E: 174.71
Forward P/E: 21.84
P/FCF: 20.86
P/S: 6.89
P/B: N/A
EPS: $1.3
EPS (fwd): $10.6
FCF/share: $11.1
Revenue/share: $33.7
Book value/share: $-1.5
ROIC: 3.3%
ROA: 1.7%
ROE: 140.9%
Debt/Equity: 48
Current Ratio: 0.70
Gross margin: 71.5%
Operating margin: 24.1%
Net margin: 4.0%
Dividend/share: $6.6
Div. yield: 2.82%
TTM Financials
Income (TTM)
Revenue$59.64(B)
Gross profit$42.62(B)
EBITDA$29.52(B)
Net income$2.39(B)
Gross margin71.5%
Operating margin24.1%
Net margin4.0%
Shares outstanding1.77(B)
Balance sheet
Total assets$133.90(B)
Current assets$28.54(B)
Total liabilities$136.50(B)
Current liabilities$39.39(B)
Cash & Short-term inv.$5.67(B)
Long-term debt$63.08(B)
Total intangibles$89.94(B)
PP&E$5.48(B)
Cash flow (TTM)
FCF$19.68(B)
CapEx$-1.18(B)
Dividends paid$-11.50(B)
Stock issued$134.00(M)
Stock repurchased$-1.33(B)
Stock-based comp.$1.47(B)
Debt issued$11.79(B)
Debt repaid$-14.56(B)